IMCITE
LIVE

Serial Number

98253891

Owner

OncoSeer Diagnostics, Inc.

Attorney

Carissa L. Bouwer, Esq.

Filing Date

Nov 3, 2023

Add to watchlist:

No watchlists yet
View on USPTO

IMCITE Trademark

Serial Number: 98253891

IMCITE is a trademark filed by OncoSeer Diagnostics, Inc. on November 3, 2023. The trademark is classified under Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

OncoSeer Diagnostics, Inc.

3060 Pegasus Park Drive Building 6
Dallas, TX 75247

Entity Type: 03

Trademark Details

Filing Date

November 3, 2023

Registration Date

Not Registered

Goods & Services

Medical apparatus, instruments and equipment for medical analysis, namely, autostainers, scanners; medical apparatus and instruments for providing information on diagnostics or identification of biological systems, namely, medical testing devices and diagnostic apparatus for detecting, analysing or assessing a cancer, tumor or equivalent medical condition; medical instruments for cancer cell detection; Biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for testing biomarkers; biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for evaluating appropriate immunotherapy cancer treatments; cancer screening tests and devices, namely, medical devices for detecting risk factors and probability of cancer reoccurrence; cancer screening tests and devices, namely, medical devices for evaluating immunotherapy cancer treatment options; cancer screening tests and devices, namely, medical devices for matching cancer diagnosis with cancer treatments; medical testing device for diagnosing cancer and detecting biological traits that effect the risk of reoccurrence; medical diagnostic apparatus for testing a patient's response to various immunotherapy cancer treatment options in order to help determine the most effective course of treatment for that patient; blood testing apparatus for cancer diagnosis and evaluation of treatment options; medical testing devices for tumor diagnosis and treatment evaluation; medical testing kit for predicting toxicity or adverse events from a cancer treatment; medical testing kit for diagnosing toxicity or adverse events from a cancer treatment

Filing History

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 31, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 28, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 27, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 26, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 21, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 6, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 6, 2024 GNSL
SUSPENSION LETTER WRITTEN
Sep 6, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 5, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 5, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 5, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 20, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 20, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 20, 2024 CNRT
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 20, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 20, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jun 20, 2024 CNSL
ASSIGNED TO EXAMINER
Jun 13, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 22, 2023 NWOS
NEW APPLICATION ENTERED
Nov 7, 2023 NWAP